20
Participants
Start Date
April 5, 2007
Primary Completion Date
November 25, 2008
MS-325 Injection (Gadofosveset Trisodium)
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
National Heart, Lung, and Blood Institute (NHLBI)
NIH